Product information

Current status:

Cancelled Post Market

Current status date:

2009-10-15

Original market date: ^{See footnote 1}

1997-07-08

Product name:

GEN-TEMAZEPAM 30MG

DIN:

02231616 Electronic product monograph is not available

Company:

GENPHARM ULC
85 Advance Road
Etobicoke
Ontario
Canada M8Z 2S6

Class:

Human

Dosage form(s):

Capsule

Route(s) of administration:

Oral

Number of active ingredient(s):

1

Schedule(s):

Targeted (CDSA IV)

American Hospital Formulary Service (AHFS): ^{See footnote 3}

28:24.08 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

N05CD07 TEMAZEPAM

Active ingredient group (AIG) number:^{See footnote5}

0114415001